Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating RELEARN Neurofeedback as Treatment for Chronic Musculoskeletal Pain

NCT05335486 is registered in ClinicalTrials.gov with Redo-Neurosystems as lead sponsor.

NCT NCT05335486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05335486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating RELEARN Neurofeedback as Treatment for Chronic Musculoskeletal Pain
Lead sponsor
Redo-Neurosystems
Phase
Phase 2/3
Overall status
Withdrawn
Start date
October 5, 2022
Completion date
July 1, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic knee pain, chronic pain, osteoarthritis